ALPCO Revenue and Competitors

Salem, NH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ALPCO's estimated annual revenue is currently $12.2M per year.(i)
  • ALPCO's estimated revenue per employee is $155,000

Employee Data

  • ALPCO has 79 Employees.(i)
  • ALPCO grew their employee count by 7% last year.

ALPCO's People

NameTitleEmail/Phone
1
CEO and PresidentReveal Email/Phone
2
CEOReveal Email/Phone
3
CFOReveal Email/Phone
4
CEOReveal Email/Phone
5
VP, Scientific OperationsReveal Email/Phone
6
VP Strategic Marketing & Business DevelopmentReveal Email/Phone
7
WW VP Product Management and Marketing, ALPCO and GeneproofReveal Email/Phone
8
Chief Commercial Officer (CCO)Reveal Email/Phone
9
Global Marketing DirectorReveal Email/Phone
10
Office Manager, Customer Solutions LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M681%N/AN/A
#2
$4.3M284%N/AN/A
#3
$2M138%N/AN/A
#4
$1.1M70%N/AN/A
#5
$3.7M24-11%N/AN/A
#6
$1.1M70%N/AN/A
#7
$45.3M292-9%N/AN/A
#8
$1.4M90%N/AN/A
#9
$2M138%N/AN/A
#10
$7M45-34%N/AN/A
Add Company

What Is ALPCO?

American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay based products for the North American life science markets. Our origin began through an exclusive partnership with one European manufacturer and has since grown into a premier channel representing over 60 collaborating partners from around the globe. In 2007, we expanded our capabilities with the launch of our organically developed product line focused in the area of diabetes and obesity research while also remaining true to our roots by continuing to provide “Immunoassays Beyond the Ordinary.” As the research and diagnostic endeavors of our customers continue to evolve, so does ALPCO’s commitment to providing high quality products and superior customer support. Over the years we’ve expanded our offering into applications for HPLC, LC-MS/MS, purified antibodies, recombinant proteins, flow cytometry reagents and recently launched our new STELLUX® line of chemiluminescent based detection systems in 2013. Additionally, our promise to provide optimal support continues to progress through a growing network of valuable online resources, collaborative relationships, and customized technical solutions. While our vision has evolved to serve a broader segment of life science research and healthcare professionals, our mission to deliver “Scientific Solutions for Life” remains the same.

keywords:N/A

N/A

Total Funding

79

Number of Employees

$12.2M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M808%N/A
#2
$21.6M804%N/A
#3
$21.6M8054%N/A
#4
$23.5M8111%N/A
#5
$21.9M81-2%N/A